Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.45 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SYK | P43405 | 1/20 | 0.38 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1891888 | 0.92 | CYP4F2 (0.42) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 | |
| SCHEMBL38659422 | 0.92 | CYP4F2 (0.42) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 | |
| SCHEMBL1892714 | 0.90 | MTNR1A (0.47) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 | |
| SCHEMBL35843127 | 0.90 | MTNR1A (0.47) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 | |
| SCHEMBL35843149 | 0.88 | FFAR1 (0.43) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 | |
| SCHEMBL1808781 | 0.88 | FFAR1 (0.43) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 | |
| SCHEMBL1888431 | 0.87 | FFAR1 (0.42) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 | |
| SCHEMBL36006022 | 0.87 | FFAR1 (0.42) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 | |
| SCHEMBL16605158 | 0.85 | FFAR1 (0.54) | FFAR1FFAR4MMP2MMP3CNR2 | |
| SCHEMBL12652650 | 0.85 | FFAR1 (0.41) | CYP4F2CYP4A11ALDH1A1GAAFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150320730-A1 | GPBP-1 inhibition and its therapeutic use | FIBROSTATIN, S.L. (ES) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150320730-A1 | GPBP-1 inhibition and its therapeutic use | ABCC1, ABCC8, ABCB1 | CYP4F2 2791/4885CYP4A11 3142/4885ALDH1A1 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.